Colbiom

Colbiom is a Spanish biotechnology company specializing in the development of non-invasive diagnostic tools for colorectal cancer based on gut microbiome analysis. The company's flagship product is a molecular diagnostic test that identifies specific microbial signatures associated with the early stages of colorectal neoplasia. By leveraging advanced metagenomic sequencing and bioinformatics, Colbiom aims to improve the accuracy and patient compliance of current screening methods. The company is a spin-off from the University of Granada and the Andalusian Health Service. Its technology focuses on identifying dysbiosis patterns that serve as early indicators of oncological risk.